Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhanced Vision and Imaging Tests for Enabling Treatment Trials in Early and Intermediate AMD

NCT07515521 is registered in ClinicalTrials.gov with Maximilian Pfau as lead sponsor.

NCT NCT07515521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07515521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhanced Vision and Imaging Tests for Enabling Treatment Trials in Early and Intermediate AMD
Lead sponsor
Maximilian Pfau
Phase
Observational
Overall status
Recruiting
Start date
February 15, 2026
Completion date
December 15, 2028
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age - related macular degeneration (amd)